A phase I clinical trial of vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small cell lung cancer.

Trial Profile

A phase I clinical trial of vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small cell lung cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Aug 2015

At a glance

  • Drugs Carboplatin; Cisplatin; Gemcitabine; Vorinostat
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 04 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Jan 2010 Planned end date changed from 1 Jan 2010 to 1 Apr 2010 as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Planned number of patients changed from 50 to 61 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top